IRADIMED Reports Record Revenues for Q4 2024 and Full-Year 2024

Iradimed Corporation (NASDAQ: IRMD), a company specializing in innovative Magnetic Resonance Imaging (MRI) compatible medical devices, has released its preliminary unaudited revenue figures for the fourth quarter and full-year 2024. The company announced that it anticipates total revenue for the fourth quarter of 2024 to be in the range of approximately $19.2 million to $19.4 […]

Leave a Reply

Your email address will not be published.

Previous post ST Germain D J Co. Inc. Purchases 306 Shares of McDonald’s Co. (NYSE:MCD)
Next post ST Germain D J Co. Inc. Has $12.10 Million Position in AbbVie Inc. (NYSE:ABBV)